BPG is committed to discovery and dissemination of knowledge
Articles in Press
6/15/2026 6:25:18 AM | Browse: 7 | Download: 4
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Review |
| Article Title |
Cuproptosis in gastric cancer: Mechanisms and therapeutic opportunities
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Yi-Ping Fang, Shu-Ni Liu, Feng-Ping Liu, Jing-Wen Gong, Yi-Fan Zhang, Jun-Hui Lu, Jing-Wei Liu, Qing Wang and Xing Chen |
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Construction and Validation of a Prognostic Risk Scoring Model Related to Cuproptosis-Characteristic Genes in Gastric Cancer |
SYYYRC-2022002 |
| Evaluation of the Efficacy and Safety of Different Doses of Saccharomyces boulardii Combined with Dual Regimens for the Eradication of Helicobacter pylori |
ITT-2025-125 |
|
| Corresponding Author |
Xing Chen, MD, Department of Gastroenterology, The First Hospital of Shanxi Medical University, No. 56 Xinjian South Road, Taiyuan 030001, Shanxi Province, China. chen0419xing@163.com |
| Key Words |
Cuproptosis; Copper metabolism; Gastric cancer; Tumor microenvironment; Immunotherapy; Copper ionophores; Copper chelators; Nanomedicine; Biomarkers |
| Core Tip |
Cuproptosis connects copper imbalance with mitochondrial metabolic vulnerability, angiogenesis, immune regulation, and treatment resistance in gastric cancer. This review summarizes copper homeostasis, protein lipoylation, oncogenic signaling, the tumor microenvironment, and copper-modulating therapies. It highlights copper ionophores, chelators, nanomedicine, and biomarkers, including ferredoxin 1, amine oxidase copper-containing 1, integrin beta 1, and serpin family E member 1, for patient stratification and rational combination therapy while emphasizing toxicity and translational challenges. |
| Citation |
Fang YP, Liu SN, Liu FP, Gong JW, Zhang YF, Lu JH, Liu JW, Wang Q, Chen X. Cuproptosis in gastric cancer: Mechanisms and therapeutic opportunities. World J Gastrointest Oncol 2026; In press
|
| PDF |
123002-in-press.pdf
|
 |
Received |
|
2026-05-06 03:21 |
 |
Peer-Review Started |
|
2026-05-06 03:21 |
 |
First Decision by Editorial Office Director |
|
2026-05-15 09:33 |
 |
Return for Revision |
|
2026-05-15 09:33 |
 |
Revised |
|
2026-05-21 06:32 |
 |
Publication Fee Transferred |
|
2026-05-25 06:38 |
 |
Second Decision by Editor |
|
2026-06-15 02:39 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2026-06-15 06:25 |
 |
Articles in Press |
|
2026-06-15 06:25 |
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
|
| ISSN |
1948-5204 (online) |
| Open Access |
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Copyright |
©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.